IncellDx, a company that's marketing a diagnostic and treatment plan for long COVID, says it's not at all associated with the Front Line COVID-19 Critical Care Alliance (FLCCC) after being listed on ...
Bio-Reference Laboratories Inc., a publicly traded company, has invested an undisclosed amount in InCellDx Inc., a molecular diagnostics start-up. Details of the round were not released. Bio-Reference ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--IncellDx today announced it has been granted U.S. Patent No. 11,180, 491 by the U.S. Patent and Trademark Office (“USPTO”) for methods of treating coronaviruses ...
IncellDx’s Chronic COVID Treatment Center (CCTC) (www.covidlonghaulers.com) and ARISE™ MD Integrative Medicine & Surgery announced today a new partnership to evaluate CCR5 antagonists and statins as a ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--IncellDx, a precision medicine company advancing novel diagnostics and prognostics to better understand and treat infectious disease and cancer, today announced ...
SAN CARLOS, Calif., Oct. 20, 2020 /PRNewswire/ -- IncellDx will collaborate on the SARS-CoV2 Clinical Trial NCT04435522 involving Pfizer's FDA-approved CCR5 antagonist Maraviroc. The trial "Open-Label ...
SAN CARLOS, Calif., Sept. 24, 2020 /PRNewswire/ -- IncellDx, Inc., a global leader in single-cell diagnostics, announces the USPTO has issued patent US10,782,298 to IncellDx. This patent covers a ...
The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the ...
Frost & Sullivan (F&S), an international management consultancy that identifies best practices in research, will present IncellDx with a Leadership Award in the Molecular Diagnostics Market. F&S cited ...
The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care. Dr. John Feller, ...
SAN CARLOS, Calif. — IncellDx, Inc., a global leader in single-cell diagnostics, announces approval by the Costa Rican Ministry of Health of its Next Generation HPV/cervical cancer assay, OncoTect 3Dx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results